NDC11 72789044930
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 72789-0449-30 | 72789-0449 |
| 72789-449-30 | 72789-449 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TEMAZEPAM | TEMAZEPAM | PD-Rx Pharmaceuticals, Inc. | 97afda58-4daf-4192-bd87-3ccbb000ee52 | 2025-10-14 | Boxed warning, Warnings, Adverse reactions | 72789-449-30 72789-449 72789044930 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.